WEST COLUMBIA, S.C. (WIS) - The FDA filed a letter warning a West Columbia pharmaceutical company to correct violations or it may face seizure or injunction. Nephron Pharmaceutical has been under ...
Figure 1: Differentiation of hPSCs into posterior intermediate mesoderm. Figure 3: Induction of pretubular aggregates and renal vesicles from nephron progenitor cells. Electron microscopy of the ...
Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...
The Clinical Implications of Basic Research series has focused on highlighting laboratory research that could lead to advances in clinical therapeutics. However, the path between the laboratory and ...
Most accepted pharmacologic treatments for heart failure are supported by evidence from large clinical trials. In contrast, evidence from large, well-controlled clinical trials to guide the use of ...
LOS ANGELES--(BUSINESS WIRE)--WhiteHawk Capital Partners, LP ("WhiteHawk"), a private credit investment manager focused on asset-based financing solutions, announced it has entered into an agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback